Evidence map›Paper›PMID 39941037›Full record

ArticleInternational journal of molecular sciences2025

FCRL1 and BAFF mRNA Expression as Novel Diagnostic and Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma: Expression Signatures Predict R-CHOP Therapy Response and Survival.

Hiba S Al-Amodi, Hanan M Bedair, Suzy Gohar, Dalia Abdel-Wahab Mohamed, Eman M Abd El Gayed, Mahmoud Nazih, Sahar Badr Hassan, Eman S Sawan, Esraa Elsayed Elmahdy, Asmaa Mosbeh and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Emerging Roles of Fc Receptor-Like 1 in Immunotherapy of Diffuse Large B-Cell Lymphoma.Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hiba S Al-AmodiBiochemistry Department, Faculty of Medicine, Umm Al-Qura University, Makkah 21955, Saudi Arabia.ORCID 0000-0003-1865-0004
Hanan M BedairClinical Pathology Department, National Liver Institute, Menoufia University, Menofia 32511, Egypt.ORCID 0000-0002-2229-3129
Suzy GoharClinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Menoufia University, Menofia 32511, Egypt.ORCID 0000-0003-3250-5954
Dalia Abdel-Wahab MohamedMedical Biochemistry and Molecular Biology Department, Faculty of Medicine, Ain Shams University, Cairo 11381, Egypt.
Eman M Abd El GayedMedical Biochemistry and Molecular Biology Department, Faculty of Medicine, Menoufia University, Menofia 32511, Egypt.
Mahmoud NazihAl Ryada University for Science and Technology (RST), ElMehwar ElMarkazy-2, Cairo-Alex Desert RD K92, Sadat City 16504, Egypt.
Sahar Badr HassanDepartment of Clinical Pharmacy, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt.
Eman S SawanDepartment of Clinical Pharmacy, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr, Cairo 11828, Egypt.
Esraa Elsayed ElmahdyMedical Microbiology and Immunology Department, Faculty of Medicine, Menoufia University, Menofia 32511, Egypt.
Asmaa MosbehFellow at Pathology Department, National Liver Institute, Menoufia University, Menofia 32511, Egypt.
Alaa EfatHematology Department, Faculty of Medicine, Menoufia University, Menofia 32511, Egypt.ORCID 0000-0001-8148-3443
Shimaa AbdelsattarClinical Biochemistry and Molecular Diagnostics Department, National Liver Institute, Menoufia University, Menofia 32511, Egypt.ORCID 0000-0002-3993-5378

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the diagnostic, prognostic, and therapeutic significance of Fc receptor-like 1 (

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsB-Cell Activating FactorBiomarkers, TumorLymphoma, Large B-Cell, DiffuseReceptors, FcAdultAgedCyclophosphamideDoxorubicinFemaleGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateMaleMiddle AgedPrednisoneB-Cell Activating FactorBiomarkers, TumorCyclophosphamideDoxorubicinPrednisoneR-CHOP protocolReceptors, FcRituximabRNA, MessengerTNFSF13B protein, humanVincristineBAFFB-cell non-Hodgkin lymphomaDLBCLFCRL1mRNA expressionR-CHOP therapy

Identifiers

PMID39941037
PMCPMC11818594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.